Company / Net Debt per Share
Organon & Co. Net Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$31.30
FY2025
5-year range
$31.30 / $33.12
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
#7 of 82
Health Care
What the data says
Among 82 Health Care companies, Organon & Co. is in the bottom 9% for net debt per share. Net Debt per Share has fluctuated over the past 6 years, ranging from $-0.05 in FY2020 to $33.12 in FY2021.
Based on SEC 10-K filings.
31.30 in FY2025 with a 3-year CAGR of -1.1%. Top quartile in the Health Care sector.
Remained stable around $31.30 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 82This company $31.30 Sector average $1.13
▼
+2669.7% above sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 2.5% year-over-year.
- Ranks #7 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2021.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $31.30 | -2.5% |
| FY2024 | $32.10 | +1.2% |
| FY2023 | $31.71 | -2.0% |
| FY2022 | $32.37 | -2.3% |
| FY2021 | $33.12 | +70065.6% |
| FY2020 | -$0.05 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026